Skip to main content

Marvin Donald's Form 4 filing

Chemomab Therapeutics Ltd. (CMMB) · filed Mar 21, 2022

Accession no.
0001178913-22-001179
Filed
Mar 21, 2022
Trade date
Nov 8, 2021-Mar 14, 2022
Filing delay
133 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market purchases total $5.04K. It was filed 133 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Marvin DonaldCIK 0001891264Officer (Executive VP, CFO & COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 14, 2022American Depositary SharesPPurchaseAcquired+250$4.00+$1,000250Direct
Mar 14, 2022American Depositary SharesPPurchaseAcquired+250$3.98+$995500Direct
Mar 14, 2022American Depositary SharesPPurchaseAcquired+250$3.90+$9751,000Direct
Mar 14, 2022American Depositary SharesPPurchaseAcquired+250$4.10+$1,0251,250Direct
Mar 14, 2022American Depositary SharesPPurchaseAcquired+250$4.20+$1,0501,500Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 8, 2021American Depositary SharesAGrant or awardAcquired+196,875$0.00$0196,875Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)